TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNovoCure Ltd.

About this trial

The purpose of this post-authorisation medical device study is to obtain real life data on the use of Tumor Treating Fields (TTFields) in patients with pleural mesothelioma in routine clinical care. Patients with pleural mesothelioma and clinical indication for TTFields treatment will be enrolled in the study after signing Informed consent to use their data and process it centrally for research purposes. The clinical indication for TTFields is one of the inclusion criteria and is defined prior to inclusion by the treating physician.

Eligibility criteria

Qualifiers

≥ 18 years of age

Histologically confirmed pleural mesothelioma without any option of curative resection

Planned treatment with NovoTTF-200T System according to IFU and medical guidelines

Life expectancy more than 3 months at day of enrollment

Disqualifiers

None

Trial design

Treatments tested in this trial

  • TTFields

Treatment groups

198 Participants
are divided into 1 treatment group

Sponsors and collaborators